By means of 5α-reductase inhibitory activity-guided fractionation, a new lanostanoid, 15α-hydroxy-3-oxolanosta-7, 9(11), 24(E)-trien-26-oic acid, named as ganoderic acid TR, was isolated from the ethanol extract of the fruiting bodies of Ganoderma lucidum (Fr.) Karst (Ganodermataceae). The compound showed potent inhibitory activity with an IC 50 of 8.5 µM. Modified Mosher's method established the S-configuration of the secondary hydroxyl group at C-15. In addition, a carboxyl group on the side chain of ganoderic acid TR is essential to elicit the inhibitory activity because of the considerably lower activity of its methyl ester.
Nowadays, androgen-mediated diseases such as prostate cancer, hirsutism, acne, androgenic alopecia, and benign prostatic hyperplasia (BPH) are considered to be a serious problem [1, 2] . Above all, BPH is one of the most common symptoms seen in older men, and 40% of men 50-60 years of age and 90% of those 80-90 years of age are diagnosed with BPH. The principal prostatic androgen is dihydrotestosterone (DHT), which is synthesized by steroid enzyme 5α-reductase from its substrate, testosterone [3] . Since the weight of the seminal vesicles depends on the 5α-reduced androgens, it is important to maintain adequate levels of DHT. Because BPH therapy can reduce DHT levels by blocking its conversion from testosterone, 5α-reductase inhibitors could be useful in the treatment of this problem [4] .
For thousands of years, mushrooms have been known as a source of medicine. Ganoderma lucidum (Ganodermataceae) called Ling Zhi in China and Reishi in Japan, is a wood rotting fungus, generally found growing on tree stumps. For a long time, G. lucidum has been considered to promote longevity and maintain the vitality of humans. Recently, the ethanol extract was reported to promote metabolism and show antiaging effects [5] . Modern research has shown that the main bioactive compounds in G. lucidum are polysaccharides and ganoderic acids, a group of triterpenes [6, 7] . Over one hundred highly oxygenated and pharmacologically active triterpenes have been isolated from this mushroom [8] , and these compounds have been proven to display wideranging biological activities; some of these are cytotoxicity against Meth-A cells [9, 10] , promotion of apoptosis of hepatoma HuH-7 cells [11] , inhibition of histamine release [12] , inhibition of angiotensin converting enzyme [13] , and antitumor promoting [14] and cholesterol synthetic inhibiting [15, 16] effects.
In our previous screening of mushrooms, we discovered that the ethanol extract of G. lucidum (Fr.) Karst. showed the strongest 5α-reductase inhibitory activity. Also, treatment with either G. lucidum itself or the ethanol extract prepared from it significantly inhibited the growth of the ventral prostate induced by testosterone in rats [17, 18] . In the course of our search for anti-androgenic components from G. lucidum, ganoderic acid DM exhibited 5α-reductase inhibitory activity [19] . We have now isolated from the fruiting body of the same species a new oxygenated lanostane-type triterpenoid, named ganoderic acid TR (1), which exhibits potent 5α-reductase inhibitory activity. In our previous screening of 19 edible and medicinal mushrooms, we discovered that the ethanol extract of G. lucidum showed the strongest 5α-reductase inhibitory activity [5, 6] . An ethanol extract of the fruiting bodies of G. lucidum was subjected to repeated chromatography on silica gel, followed by preparative HPLC, guided by 5α-reductase inhibitory activity to give ganoderic acid TR (1) as a 5α-reductase inhibitory component. 5 .38 (d, J = 6.0 Hz), and 6.88 (t, J = 6.7 Hz). The 13 C NMR also showed signals due to a conjugated diene group at δ 121.1, 140.9, 144.7, and 116.9, which suggested a 7, 9(11)-diene lanostane skeleton. The UV absorptions at 232, 243 and 253 nm (log ε 3.6, 3.8, 3.5) supported the presence of a heteronuclear conjugated 7, 9-diene skeleton. Examination of the 13 C NMR chemical shifts of C-1 to C-21 and C-H correlations obtained from HMQC and HMBC clearly indicated the A-B-C-D ring structure. As regards the stereochemistry at C-24, NOESY experiments did not yield the NOE cross peak between H-24 and H 3 -27, suggesting an E configuration.
Furthermore, these NMR characteristics closely resembled those of ganodericacid T-Q, except for an acetoxy substituent at C-15 [20] . Determination of the absolute configuration at C-15 was undertaken using a modification of Mosher's method [21] . Under the standard reaction conditions with (R)-(+)-and (S)-(-)-MTPA for 6 hr, the compound gave 15-(R)-(+)-MTPA ester and 15-(S)-(-)-MTPA ester, respectively. In the 1 H-NMR spectrum of (S)-(-)-MTPA ester, proton signals assigned to H-16 and H-17 were observed at higher fields than those in the (R)-(+)-MTPA ester, while signals due to H-14 and H-6 in the former ester were shifted to lower fields than those in the latter ester. Therefore, the absolute configuration at C-15 was concluded to be (S). Consequently, the structure was determined to be 15α-hydroxy-3-oxolanosta-7, 9(11), 24(E)-trien-26-oic acid, named as ganoderic acid TR. The effect of ganoderic acid TR (1) on 5α-reductase showed that inhibition of the enzyme was concentration-dependent, as shown in Figure 3 . As the concentration of 1 increased, the residual enzyme activity was rapidly decreased, but was not completely suppressed. The inhibitor concentration leading to 50% activity loss (IC 50 ) was estimated to be 8.5 µM. In contrast to 1, its methyl ester (2) showed much less inhibitory activity, as shown in Figure 3 . These results suggested that a carboxyl group in the side chain of 1 is essential to elicit the inhibitory activity, but the reason for this difference of inhibition is still largely unknown and there still seems to be a lack of important knowledge for designing effective 5α-reductase inhibitors.
Experimental
General experimental procedures: Optical rotation was measured on a Horiba SEPA-300 polarimeter. Melting points were recorded on a Yanagimoto micro-melting point apparatus. The UV spectra were obtained using a Waters 996 Photodiode Array Detector. The 1 H NMR and 13 C NMR spectra were recorded on JEOL JNM-AL400 spectrometers. FABMASS spectra were measured on JEOL JMS-700 spectrometers. 1H, m, 1α-H Preparation of methyl ester (2): N-methyl-N-nitrosop-toluene sulfonamide (1.25 g, 5.83 mmol) was dissolved in diethyl ether (60 mL), and dropped into the solvent that included KOH (0.7 g, 12.5 mmol), ethanol (1.6 mL) and water (0.5 mL). The water bath was not higher than 60˚C. The solution of diazomethane (CH 2 N 2 ) was collected into a flask, and put into 1 until bubbles were no longer produced. The diethyl ether was dried to yield a white powder. The methyl ester (2) was confirmed by GC-MS ([M + ] 482).
Preparation of rat microsomes:
Rat liver from female SD rats (7 weeks age) was prepared by a method previously reported by Shimizu et al with some modifications [22] . From two mature SD female rats, the livers were removed and minced tissue was homogenized in 4 tissue volumes of medium A (0.32 M sucrose, 1 mM dithiothreitol, and 20 mM sodium phosphate, pH 6.5). The resulting supernatant from the centrifugations was further centrifuged at 105,000 × g for 2 x 1 hour. The washed microsomes were suspended in 1 pellet volume of medium A, and dispersion of microsomes was achieved using a syringe with 18 G, 23 G, and 26 G needles in succession. The microsome suspension was stored at -70ºC until just before use.
Measurement of 5α-reductase inhibitory activity:
A complete reaction mixture included 1mM dithiothreitol, 20 mM phosphate buffer (pH 6.5), 1.9 nCi [4-14 C] testosterone, 150 µM testosterone, 167 µM NADPH, and the enzyme preparation (0.6 mg of protein) in a final volume of 0.3 mL. The concentration of testosterone contributed by [4- 14 C] testosterone was negligible. The new compound and the methyl ester were added to the solution at each concentration. Incubation was carried out for 10 min 5α-Reductase inhibiting lanostanoid from Ganoderma lucidum Natural Product Communications Vol. 1 (5) 2006 349 at 37˚C and was started by the addition of 10 µL microsomes to the pre-heated reaction solution in a tube. After 10 min, incubation was terminated by adding 10 µL of 3 M NaOH. To extract metabolites, 1 mL of diethyl ether was added, and the tubes were capped and shaken. The organic phase was applied to a silica plate (Kieselgel 60 F 254 ), which was developed in ethyl acetate-n-hexane (7:3) at room temperature. The radioactivity profile was determined with an imaging analyzer (FLA-5000 RF, Fuji Film Co., Ltd. Tokyo, Japan). The 5α-reductase activity was calculated from the percentage conversion of [4- 14 C] testosterone to [4-14 C] dihydrotestosterone.
